FDA Approves Conjupri (levamlodipine maleate) for the Treatment of Hypertension

Hong Kong, 20 December 2019 -- The board of directors (the“Board”) of CSPC Pharmaceutical Group Limited (the“Company”, together with its subsidiaries, the“Group”) is pleased to announce that Conjupri®...
Source: Drugs.com - New Drug Approvals - Category: Drugs & Pharmacology Source Type: news